AAAAAA

   
Results: 1-9 |
Results: 9

Authors: WRIGHT A CULL C HOLMAN R TURNER R MURCHISON L WRIGHT AD OAKLEY N KOHNER E HAYES R SCARPELLO J HADDEN D SPATHIS AG YUDKIN J GREENWOOD R BORTHWICK L DAY J NEWTON R FOX C PAISEY R ROLAND J HUMPHRISS D PEACOCK I BOULTON A DORNAN T BURDEN F TOOKE J
Citation: A. Wright et al., UNITED-KINGDOM PROSPECTIVE DIABETES STUDY-24 - A 6-YEAR, RANDOMIZED, CONTROLLED TRIAL COMPARING SULFONYLUREA, INSULIN, AND METFORMIN THERAPY IN PATIENTS WITH NEWLY-DIAGNOSED TYPE-2 DIABETES THAT COULD NOT BE CONTROLLED WITH DIET THERAPY, Annals of internal medicine, 128(3), 1998, pp. 165-175

Authors: PEACOCK I JEFFCOATE WJ
Citation: I. Peacock et Wj. Jeffcoate, CORTICOTROPIC MACROADENOMA OF THE PITUITARY ASSOCIATED WITH HYPOADRENALISM, Clinical endocrinology, 46(6), 1997, pp. 765-768

Authors: BROWN CJ DAWSON A DODDS R GAMSU H GILLMER M HALL M HOUNSOME B KNOPFLER A OSTLER J PEACOCK I ROTHMAN D STEEL J
Citation: Cj. Brown et al., REPORT OF THE PREGNANCY AND NEONATAL CARE GROUP, Diabetic medicine, 13(9), 1996, pp. 43-53

Authors: PAGE SR LLOYD CA HILL PG PEACOCK I HOLMES GKT
Citation: Sr. Page et al., THE PREVALENCE OF CELIAC-DISEASE IN ADULT DIABETES-MELLITUS, Quarterly Journal of Medicine, 87(10), 1994, pp. 631-637

Authors: PAGE SR MANNING G INGLE AR HILL P MILLARCRAIG MW PEACOCK I
Citation: Sr. Page et al., RAISED AMBULATORY BLOOD-PRESSURE IN TYPE-1 DIABETES WITH INCIPIENT MICROALBUMINURIA, Diabetic medicine, 11(9), 1994, pp. 877-882

Authors: PAGE SR PEACOCK I
Citation: Sr. Page et I. Peacock, BLOOD-GLUCOSE MONITORING - DOES TECHNOLOGY HELP, Diabetic medicine, 10(9), 1993, pp. 793-801

Authors: COWLEY C BAINBRIDGE MA JOHNSON AB SCOTT AR PEACOCK I
Citation: C. Cowley et al., THE DERBYSHIRE INITIATIVE, Diabetes, nutrition & metabolism, 6(6), 1993, pp. 343-344

Authors: PAGE SR MANNING G INGLE AR HILL PG MILLARCRAIG MW PEACOCK I
Citation: Sr. Page et al., RAISED AMBULATORY BLOOD-PRESSURE PRECEDES THE ONSET OF MICROALBUMINURIA IN INSULIN-DEPENDENT DIABETES, Diabetologia, 36, 1993, pp. 10000214-10000214

Authors: BEHOUNEK BD MARKOWITZ JS BERGMAN M MCGOVERN ME KASSLERTAUB KB VANHANEN H ELORANTA M JUVONEN J KANTOLA I KEKKI S KIVELA H KNUTAR F NISSEN M SALMI J SALONEN R TARPILA S TUNTURIHIHNALA H AMANN FW BERENDES G BONNER G DUBACH UC EGGSTEIN M FRANKENBERG HV FROER KL HOHL H HOPPE F KUMMER H MARZ W MOCCETTI T NOSEDA G REUTTER FW SCHWENKE R VOSSCHULTE G WAMBACH G WEIDMANN P BONNIER JJRM DEWEERD P HUIGE MC JANSEN LJ TERIJDT AJ TEVELDE K OLSSON AG LARSSON H ASPLUND J DAHLQVIST A LONNQVIST F FRITHZ G HOGLUND C KJELLSTROM T KUYLENSTIERNA J MOLLER B OSTERGREN J CRAMB R DAVIES J",IVERSON,"JOHNSTON GD MUNRO A PEACOCK I RITCHIE LD RITTER J RYLANCE PB SEVER PS SIMMONS RL
Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037
Risultati: 1-9 |